Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06370988

Theta-Burst Stimulation for Bipolar Depression

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
124 (estimated)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this trial is to determine if intermittent theta-burst stimulation (iTBS) can reduce the symptoms of depression in treatment-resistant bipolar disorder. To do this, some of the participants in this study will receive treatment with active iTBS stimulation, while others will receive sham iTBS stimulation. Participants will come for 30 days of either active iTBS or sham iTBS, with a 6-week follow-up period. Symptoms of depression (for determining treatment efficacy) and mania (for determining treatment safety) will be assessed using the 17-item Hamilton Rating Scale for Depression (HRSD-17) and the Young Mania Rating Scale (YMRS) every five treatments during the treatment course, and at 1 week and 6 week after treatment completion.

Conditions

Interventions

TypeNameDescription
DEVICEiTBS StimulationFluid-Cooled B70 A/P Coil with either Magventure X100 or R30
DEVICESham iTBS StimulationFluid-Cooled B70 A/P Coil with either Magventure X100 or R30

Timeline

Start date
2024-05-15
Primary completion
2029-05-01
Completion
2029-05-01
First posted
2024-04-17
Last updated
2026-03-18

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06370988. Inclusion in this directory is not an endorsement.